The field of Alzheimer disease has entered a new era of earlier detection, creating an opportunity to redefine treatment and the clinical care of patients.
Larisa Reyderman, PhD
Advertisement
Vice President, Global Head of Clinical Pharmacology and Translational Medicine, Neurology Business Group, Eisai
Articles by Larisa Reyderman, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms
2
MDS Congress 2025: Top Expert Interviews and Key Takeaways
3
A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential
4
Increasing Early Awareness of Child Neurology as a Potential Career Path: Miya Bernson-Leung, MD, EdM
5
